The enzyme polo-like kinase 1 (PLK1) may be a potential therapeutic target for squamous cell carcinoma (SCC) associated with recessive…
Articles by Steve Bryson, PhD
Among a group of people with junctional epidermolysis bullosa (JEB), nearly all genetic mutations associated with the condition were…
Researchers have highlighted the challenges of treating two cases of aggressive squamous cell carcinoma (SCC), a form of skin cancer…
Gene therapy applied to stem cells — ones derived from blister fluid collected from people with recessive dystrophic epidermolysis…
Squamous cell carcinoma (SCC), a form of skin cancer, was the most reported cancer among people with epidermolysis bullosa…
Skin-derived stem cells enhanced wound closure in people with recessive dystrophic epidermolysis bullosa (RDEB), according to clinical trial data.
People with epidermolysis bullosa (EB) have an increased risk of delayed puberty and low bone mineral density (BMD), according…
Genetic defects underlying junctional epidermolysis bullosa (JEB) can also cause kidney-urinary tract symptoms, a case series reports. Researchers recommend…
A 36-year-old woman with epidermolysis bullosa acquisita or EBA — a non-genetic type of epidermolysis bullosa (EB) — was…
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends the approval in Europe…
Plant-based kaempferol — a compound with antioxidant and anti-inflammatory properties — enhanced the production in skin cells of C7,…
An imbalance both of immune signaling proteins and mediators of the itch response was found in the bloodstream of people…